TY  - JOUR
AU  - Gomez-Garcia, Francisco
AU  - Ruano, Juan
AU  - Gay-Mimbrera, Jesus
AU  - Aguilar-Luque, Macarena
AU  - Sanz-Cabanillas, Juan L
AU  - Hernandez Romero, Jose L
AU  - Garcia-Nieto, Antonio Velez
PY  - 2018
DO  - 10.1007/s13555-018-0235-4
SN  - 2193-8210
UR  - http://hdl.handle.net/10668/12319
T2  - Dermatology and therapy
AB  - The interleukin (IL)-1 pathway has been identified as being involved in inflammatory and neoplastic skin diseases such as psoriasis, atopic dermatitis, neutrophilic dermatosis, melanoma, and squamous cell carcinoma. Drugs developed to target the IL-1...
LA  - en
PB  - Springer
KW  - Immune-mediated chronic inflammatory skin diseases
KW  - Interleukin-1-targeting drugs
KW  - PRISMA statement
KW  - Scoping review
KW  - Dermatitis, atopic
KW  - Interleukin-1
KW  - Melanoma
KW  - Dermatology
KW  - Cost-benefit analysis
KW  - Reproducibility of results
KW  - Psoriasis
KW  - Skin neoplasms
TI  - A Scoping Review Protocol to Explore the Use of Interleukin-1-Targeting Drugs for the Treatment of Dermatological Diseases: Indications, Mechanism of Action, Efficacy, and Safety.
TY  - research article
VL  - 8
ER  -